T'KYLIA MOSS-POWE: Open Payments
NPI 1588431217 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 78 payments from 35 companies in 2025. Trend: 2023 $17 · 2024 $1,456 · 2025 $1,701
Food & beverage: $1,701
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $195 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| Genentech USA, Inc. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| PharmaEssentia USA Corporation | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 1 | $68 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Incyte Corporation | 3 | $54 |
Products named: RYBREVANT, KEYTRUDA, BESREMI, Polivy, OPDIVO, EPKINLY, TECVAYLI, Orserdu.
Industry payments across MS — which companies pay providers there.
